Neuphoria Therapeutics, Inc. (NEUP)
3.87
-0.02
(-0.51%)
USD |
NASDAQ |
Dec 19, 12:28
Neuphoria Therapeutics EPS Diluted (Quarterly): -4.411 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Adverum Biotechnologies, Inc. | -2.029 |
| Aditxt, Inc. | -548.81 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| X4 Pharmaceuticals, Inc. | -0.689 |
| Inhibrx Biosciences, Inc. | -2.278 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.906M |
| Total Expenses (Quarterly) | 9.906M |
| Enterprise Value | -6.297M |
| Earnings Yield | 23.35% |
| Normalized Earnings Yield | 59.34 |